Your browser doesn't support javascript.
2020 Year in Review: Pharmacologic Treatments for COVID-19.
Saunders, Jessica L; Davis, Michael D.
  • Saunders JL; Indiana University School of Medicine, Pediatric Pulmonology, Riley Hospital for Children, Indianapolis, Indiana.
  • Davis MD; Wells Center for Pediatric Research/Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children at Indiana University School of Medicine, Indianapolis, Indiana. mdd1@iu.edu.
Respir Care ; 66(7): 1167-1172, 2021 07.
Article in English | MEDLINE | ID: covidwho-1181735
ABSTRACT
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, has led to a pandemic of acute respiratory illness. Pharmacologic treatments for COVID-19 have included treatments that target infection prevention, prevention of viral replication, reduce inflammation, and manage symptoms of respiratory failure caused by the disease. This is a review of key pharmacologic treatments for COVID-19 based on peer-reviewed articles from 2020.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Respir Care Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Respir Care Year: 2021 Document Type: Article